Item 7.01. Regulation FD Disclosure.

On July 28, 2021, PAVmed Inc. (the "Company") issued a press release announcing that medical diagnostics pioneer Stanley N. Lapidus, founder and former Chairman and CEO of Exact Sciences (Nasdaq: EXAS), had joined the Company's majority owned subsidiary, Lucid Diagnostics Inc. ("Lucid"), as Vice Chairman of Lucid's Board of Directors.

The information furnished under this Item 7.01, including the exhibit related thereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any disclosure document of the Company, except as shall be expressly set forth by specific reference in such document.

© Edgar Online, source Glimpses